Back to Search
WILLIAM MEZZANOTTE, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1972887875Individual
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
MD034338E(PA)
Research & Publications (6)
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
PMID 18446589·J Asthma·2008
4-observational
Bronchodilation of formoterol administered with budesonide: device and formulation effects.
PMID 17625985·Contemp Clin Trials·2008
4-observational
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
PMID 17697902·Clin Ther·2007
4-observational
Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy.
PMID 17109664·Int J Clin Pract·2006
2-rct
Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure.
PMID 11570617·Ann Allergy Asthma Immunol·2001
3-trial
Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).
PMID 10719780·Ann Allergy Asthma Immunol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2660 W CHESTER PIKE
BROOMALL, PA 19008 - Phone
- (610) 527-4980
Quick Facts
- NPI
- 1972887875
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile